Home

Schizophrenia

Read time: 2 min

Congress highlights

Negative symptoms improved by early intervention

New EPA guidelines on the diagnosis and management of negative symptoms should help draw attention...

How far can technology aid diagnosis and treatment?

Machine learning has potential in aiding objective psychiatric diagnosis and in the prediction of...

02:54

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes....

02:54

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes....

02:54

Read time: 2 min

Congress highlights

Why is greater investment key to better mental health?

Every individual with a mental health disorder has a unique experience. Understanding this...

Read time: 2 min

Congress highlights

PRISM casts revealing light on symptoms that cross diagnostic categories

The PRISM project is multidisciplinary, quantitative, biology-based and – above all –...

Read time: 2 min

Congress highlights

Forty thousand users and counting: science-based nomenclature takes off

Classifying drugs by mechanism of action rather than by indication should clarify the rationale for...

ECNP 2022 magazine

To prepare you for ECNP 2022, Progress in Mind Resource Center brings you a selection of...

Read time: 2 min

Congress highlights

What does person-centered care look like for patients with schizophrenia?

Person-centered treatment and care should be a vital component of psychiatry, aiming to promote the...

Read time: 3 min

Digital technology in psychosis – it’s no delusion

The application of digital interventions is starting to emerge as part of a rapidly expanding cache...

Read time: 3 min

Congress highlights

Real world study casts new light on potential of polypharmacy

The fact that 20-25% of patients with schizophrenia are treated with more than one antipsychotic1...

Read time: 2 min

Congress highlights

Addressing the unmet need of cognitive dysfunction in schizophrenia

Metacognition needs to be an important component of cognitive remediation therapy (CRT) to...

Addressing the unmet need of cognitive dysfunction in schizophrenia

Metacognition needs to be an important component of cognitive remediation therapy (CRT) to...

02:54

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Israel
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the Israel click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country